Altre lingue Fusion Antibodies plc

Azioni

Tempo differito London S.E. Altri mercati azionari 15:15:28 05/06/2024			Variaz. 5gg	Var. 1 gen.
3,5 ^GBX	+1,45%		-7,89%	-17,65%

23/05	Fusion Antibodies plc annuncia un nuovo contratto con un cliente esistente per lo sviluppo di una terapia	CI
30/04	GUADAGNI E TRADING: Software Circle e Beximco registrano un aumento dei ricavi	AN

Celadon ships to US; Oxford BioDynamics-Goodbody pact	23/05
Fusion Antibodies plc Announces New Contract with Existing Client Project to Develop Therapeutic	23/05
Fusion Antibodies reports second-half rebound as new commercial strategy pays off	09/05
EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	30/04
Fusion Antibodies inks commercial contract for OptiPhage library	15/04
Fusion Antibodies Secures Contract to Set Up OptiPhage Library	15/04
Fusion Antibodies plc Enters into Commercial Contract to Develop a Bespoke OptiPhageTM Library	15/04
Sondrel wins USD23 million contract	27/02
Fusion Antibodies Lands Antibodies Contract with Diagnostics Company	27/02
Fusion Antibodies plc Receives First Purchase Order Under the Master Services Agreement	27/02
Fusion Antibodies raises GBP1.4 million via placing	14/02
Fusion Antibodies Raises GBP1 Million via Share Issue	14/02
Fusion Antibodies strikes follow-on research and development project	06/02
Fusion Antibodies Receives Follow-On Project from US Biotechnology Client	06/02
AIM WINNERS & LOSERS: Beeks Financial Cloud is ahead of expectations	06/02
Fusion Antibodies plc Receives Follow-On Project Award and R&D Update	06/02
Fusion Antibodies gets tax credit from UK HMRC for OptiMAL platform	01/02
Fusion Antibodies Receives R&D Tax Credit from UK Government	01/02
FTSE 100 slips as miners hold down index	04/12
Fusion Antibodies shares fall with revenue despite "positive" outlook	04/12

Non ci sono risultati per questa ricerca